Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Jommi

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Pharmacoeconomics - Open|March 4, 2021
Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?Giancarlo Pruneri, Filippo De Braud, Anna Sapino, et al.
Recenti Progressi in Medicina|March 22, 2022
[Unmet clinical need and new therapeutic options.]Francesca Caprari, Alessandro Alfano, Giuliano Buzzetti, et al.
Nephron|July 18, 2018
Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE StudyMario Cozzolino, Piergiorgio Bolasco, Claudio Ronco, et al.
Recenti Progressi in Medicina|November 16, 2021
[Early access programs and managed entry agreements for medicines in Italy: results of a Focus Group (Early Access Programs and Managed Entry Agreement).]Claudio Jommi, Patrizio Armeni, Francesco Costa, et al.
Global & Regional Health Technology Assessment|May 13, 2026
More and earlier data from AIFA: do they impact on the regional policies? Results from an exploratory analysisRiccardo Novaro, Mattia Altini, Francesca Futura Bernardi, et al.
BMJ Open|September 11, 2019
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocolSilvia Riva, Jane Bryce, Francesco De Lorenzo, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 28, 2025
Single-Inhaler Triple Therapy in Primary Care Across Europe: Expert Panel Consensus on the Consequences of Payer-Driven Access Rules and Call to ActionFabiano Di Marco, Orjola Shahaj, Arschang Valipour, et al.
Journal of Medical Internet Research|August 18, 2025
The Costs of Digital Health Interventions to Improve Immunization Data in Low- and Middle-Income Countries: Multicountry Mixed Methods StudyCarlo Federici, Maria Verykiou, Marianna Cavazza, et al.
Health Systems in Transition|December 9, 2016
Pharmaceutical regulation in 15 European countries reviewDimitra Panteli, Francis Arickx, Irina Cleemput, et al.
BMJ Open|May 16, 2025
Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational studyValentina De Micheli, Luca Agnelli, Elena Conca, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Pharmacoeconomics - Open|March 4, 2021
Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach?Giancarlo Pruneri, Filippo De Braud, Anna Sapino, et al.
Recenti Progressi in Medicina|March 22, 2022
[Unmet clinical need and new therapeutic options.]Francesca Caprari, Alessandro Alfano, Giuliano Buzzetti, et al.
Nephron|July 18, 2018
Clinical Management of Chronic Kidney Disease Patients in Italy: Results from the IRIDE StudyMario Cozzolino, Piergiorgio Bolasco, Claudio Ronco, et al.
Recenti Progressi in Medicina|November 16, 2021
[Early access programs and managed entry agreements for medicines in Italy: results of a Focus Group (Early Access Programs and Managed Entry Agreement).]Claudio Jommi, Patrizio Armeni, Francesco Costa, et al.
Global & Regional Health Technology Assessment|May 13, 2026
More and earlier data from AIFA: do they impact on the regional policies? Results from an exploratory analysisRiccardo Novaro, Mattia Altini, Francesca Futura Bernardi, et al.
BMJ Open|September 11, 2019
Development and validation of a patient-reported outcome tool to assess cancer-related financial toxicity in Italy: a protocolSilvia Riva, Jane Bryce, Francesco De Lorenzo, et al.
International Journal of Chronic Obstructive Pulmonary Disease|May 28, 2025
Single-Inhaler Triple Therapy in Primary Care Across Europe: Expert Panel Consensus on the Consequences of Payer-Driven Access Rules and Call to ActionFabiano Di Marco, Orjola Shahaj, Arschang Valipour, et al.
Journal of Medical Internet Research|August 18, 2025
The Costs of Digital Health Interventions to Improve Immunization Data in Low- and Middle-Income Countries: Multicountry Mixed Methods StudyCarlo Federici, Maria Verykiou, Marianna Cavazza, et al.
Health Systems in Transition|December 9, 2016
Pharmaceutical regulation in 15 European countries reviewDimitra Panteli, Francis Arickx, Irina Cleemput, et al.
BMJ Open|May 16, 2025
Impact of comprehensive genomic profiling and molecular tumour board on costs and access to tailored therapies: real-world observational studyValentina De Micheli, Luca Agnelli, Elena Conca, et al.
Pageof 9